| Literature DB >> 33204011 |
Masaaki Funata1,2, Yasunori Nio1,2, Derek M Erion3, Wendy L Thompson4, Takanori Takebe5,6,7,8,9.
Abstract
The advent of organoid technology has enabled scientists and clinicians to utilize cells from primary tissues or pluripotent stem cells (PSCs) to grow self-organizing tissue systems, thus attaining cellular diversity, spatial organization, and functionality as found within digestive tracts. The development of human gastrointestinal (GI) and hepato-biliary-pancreatic organoids as an in-a-dish model present novel opportunities to study humanistic mechanisms of organogenesis, regeneration and pathogenesis. Herein, we review the recent portfolios of primary tissue-derived and PSC-derived organoids in the digestive systems. We also discuss the promise and challenges in disease modeling and drug development applications for digestive disorders.Entities:
Mesh:
Year: 2020 PMID: 33204011 PMCID: PMC7852589 DOI: 10.1038/s41418-020-00661-3
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 12.067